Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Diabetes

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    May 2020
  1. EICHMANN M, Baptista R, Ellis RJ, Heck S, et al
    Costimulation Blockade Disrupts CD4(+) T Cell Memory Pathways and Uncouples Their Link to Decline in beta-Cell Function in Type 1 Diabetes.
    J Immunol. 2020 May 13. pii: jimmunol.1901439. doi: 10.4049/jimmunol.1901439.
    PubMed     Abstract available


    April 2020
  2. BELMONTE PJ, Shapiro MJ, Rajcula MJ, McCue SA, et al
    Cutting Edge: ST8Sia6-Generated alpha-2,8-Disialic Acids Mitigate Hyperglycemia in Multiple Low-Dose Streptozotocin-Induced Diabetes.
    J Immunol. 2020 Apr 29. pii: jimmunol.2000023. doi: 10.4049/jimmunol.2000023.
    PubMed     Abstract available


  3. FODA BM, Ciecko AE, Serreze DV, Ridgway WM, et al
    The CD137 Ligand Is Important for Type 1 Diabetes Development but Dispensable for the Homeostasis of Disease-Suppressive CD137(+) FOXP3(+) Regulatory CD4 T Cells.
    J Immunol. 2020 Apr 15. pii: jimmunol.1900485. doi: 10.4049/jimmunol.1900485.
    PubMed     Abstract available


    March 2020
  4. IHANTOLA EL, Ilmonen H, Kailaanmaki A, Rytkonen-Nissinen M, et al
    Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes-Associated HLA Class II Molecules.
    J Immunol. 2020 Mar 30. pii: jimmunol.1901079. doi: 10.4049/jimmunol.1901079.
    PubMed     Abstract available


  5. DAVIS FM, denDekker A, Kimball A, Joshi AD, et al
    Epigenetic Regulation of TLR4 in Diabetic Macrophages Modulates Immunometabolism and Wound Repair.
    J Immunol. 2020 Mar 23. pii: jimmunol.1901263. doi: 10.4049/jimmunol.1901263.
    PubMed     Abstract available


    February 2020
  6. BERGOT AS, Buckle I, Cikaluru S, Naranjo JL, et al
    Regulatory T Cells Induced by Single-Peptide Liposome Immunotherapy Suppress Islet-Specific T Cell Responses to Multiple Antigens and Protect from Autoimmune Diabetes.
    J Immunol. 2020 Feb 28. pii: jimmunol.1901128. doi: 10.4049/jimmunol.1901128.
    PubMed     Abstract available


    October 2019
  7. ZHANG M, Ming S, Gong S, Liang S, et al
    Activation-Induced Cell Death of Mucosal-Associated Invariant T Cells Is Amplified by OX40 in Type 2 Diabetic Patients.
    J Immunol. 2019 Oct 2. pii: jimmunol.1900367. doi: 10.4049/jimmunol.1900367.
    PubMed     Abstract available


    July 2019
  8. MARTINOV T, Swanson LA, Breed ER, Tucker CG, et al
    Programmed Death-1 Restrains the Germinal Center in Type 1 Diabetes.
    J Immunol. 2019 Jul 19. pii: jimmunol.1801535. doi: 10.4049/jimmunol.1801535.
    PubMed     Abstract available


    May 2019
  9. STOCKS BT, Wilson CS, Marshall AF, Hoopes EM, et al
    Regulation of Diabetogenic Immunity by IL15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.
    J Immunol. 2019 May 24. pii: jimmunol.1800976. doi: 10.4049/jimmunol.1800976.
    PubMed     Abstract available


  10. JAMISON BL, Neef T, Goodspeed A, Bradley B, et al
    Nanoparticles Containing an Insulin-ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells.
    J Immunol. 2019 May 20. pii: jimmunol.1900127. doi: 10.4049/jimmunol.1900127.
    PubMed     Abstract available


  11. OH-HORA M, Lu X, Shiokawa M, Takayanagi H, et al
    Stromal Interaction Molecule Deficiency in T Cells Promotes Spontaneous Follicular Helper T Cell Development and Causes Type 2 Immune Disorders.
    J Immunol. 2019;202:2616-2627.
    PubMed     Abstract available


    December 2018
  12. ARMBRUST T, Millis MP, Alvarez ML, Saremi A, et al
    CXCL4L1 Promoter Polymorphisms Are Associated with Improved Renal Function in Type 1 Diabetes.
    J Immunol. 2018 Dec 28. pii: jimmunol.1801086. doi: 10.4049/jimmunol.1801086.
    PubMed     Abstract available


  13. FRYDRYCH LM, Bian G, Fattahi F, Morris SB, et al
    GM-CSF Administration Improves Defects in Innate Immunity and Sepsis Survival in Obese Diabetic Mice.
    J Immunol. 2018 Dec 21. pii: jimmunol.1800713. doi: 10.4049/jimmunol.1800713.
    PubMed     Abstract available


    November 2018
  14. JAMES EA, Gillette L, Durinovic-Bello I, Speake C, et al
    DRB4*01:01 Has a Distinct Motif and Presents a Proinsulin Epitope That Is Recognized in Subjects with Type 1 Diabetes.
    J Immunol. 2018 Nov 19. pii: jimmunol.1800723. doi: 10.4049/jimmunol.1800723.
    PubMed     Abstract available


    August 2018
  15. PRESA M, Racine JJ, Dwyer JR, Lamont DJ, et al
    A Hypermorphic Nfkbid Allele Contributes to Impaired Thymic Deletion of Autoreactive Diabetogenic CD8(+) T Cells in NOD Mice.
    J Immunol. 2018 Aug 20. pii: jimmunol.1800465. doi: 10.4049/jimmunol.1800465.
    PubMed     Abstract available


    July 2018
  16. IHANTOLA EL, Viisanen T, Gazali AM, Nanto-Salonen K, et al
    Effector T Cell Resistance to Suppression and STAT3 Signaling during the Development of Human Type 1 Diabetes.
    J Immunol. 2018 Jul 13. pii: jimmunol.1701199. doi: 10.4049/jimmunol.1701199.
    PubMed     Abstract available


    June 2018
  17. FELTON JL, Maseda D, Bonami RH, Hulbert C, et al
    Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes.
    J Immunol. 2018 Jun 27. pii: jimmunol.1701717. doi: 10.4049/jimmunol.1701717.
    PubMed     Abstract available


  18. FARNSWORTH CW, Schott EM, Benvie A, Kates SL, et al
    Exacerbated Staphylococcus aureus Foot Infections in Obese/Diabetic Mice Are Associated with Impaired Germinal Center Reactions, Ig Class Switching, and Humoral Immunity.
    J Immunol. 2018 Jun 1. pii: jimmunol.1800253. doi: 10.4049/jimmunol.1800253.
    PubMed     Abstract available


    April 2018
  19. SCHLOSS J, Ali R, Racine JJ, Chapman HD, et al
    HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression.
    J Immunol. 2018 Apr 9. pii: jimmunol.1701652. doi: 10.4049/jimmunol.1701652.
    PubMed     Abstract available


    November 2017
  20. BURG AR, Das S, Padgett LE, Koenig ZE, et al
    Superoxide Production by NADPH Oxidase Intensifies Macrophage Antiviral Responses during Diabetogenic Coxsackievirus Infection.
    J Immunol. 2017 Nov 20. pii: ji1700478. doi: 10.4049/jimmunol.1700478.
    PubMed     Abstract available


  21. HUANG W, Rainbow DB, Wu Y, Adams D, et al
    A Novel Pkhd1 Mutation Interacts with the Nonobese 1Diabetic Genetic Background To Cause Autoimmune Cholangitis.
    J Immunol. 2017 Nov 20. pii: ji1701087. doi: 10.4049/jimmunol.1701087.
    PubMed     Abstract available


  22. WHITENER RL, Gallo Knight L, Li J, Knapp S, et al
    The Type 1 Diabetes-Resistance Locus Idd22 Controls Trafficking of Autoreactive CTLs into the Pancreatic Islets of NOD Mice.
    J Immunol. 2017 Nov 6. pii: ji1602037. doi: 10.4049/jimmunol.1602037.
    PubMed     Abstract available


  23. MACCUISH AC, Irvine WJ, Barnes EW, Duncan LJP, et al
    Pillars Article: Antibodies to Pancreatic Islet Cells in Insulin-dependent Diabetics with Coexistent Autoimmune Disease. Lancet. 1974. 304: 1529-1531.
    J Immunol. 2017;199:3019-3021.
    PubMed    


  24. BOTTAZZO GF, Florin-Christensen A, Doniach D
    Pillars Article: Islet-cell Antibodies in Diabetes Mellitus with Autoimmune Polyendocrine Deficiencies. Lancet. 1974. 304: 1279-1283.
    J Immunol. 2017;199:3014-3018.
    PubMed    


  25. BUCKNER JH, Greenbaum CJ
    Stacking the Deck: Studies of Patients with Multiple Autoimmune Diseases Propelled Our Understanding of Type 1 Diabetes as an Autoimmune Disease.
    J Immunol. 2017;199:3011-3013.
    PubMed    


    October 2017
  26. WANG Q, Racine JJ, Ratiu JJ, Wang S, et al
    Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 Cotherapy.
    J Immunol. 2017 Oct 20. pii: ji1700822. doi: 10.4049/jimmunol.1700822.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: